Class-Action Suit Targets Firm Fighting Aging Via Telomerase Activation
This article was originally published in The Rose Sheet
Executive Summary
Telomerase Activation Sciences, Inc. makes claims that are “knowingly false” and fails to warn consumers about the potential risks associated with its T.A. 65 supplement, according to a class-action suit filed by a former employee.